首页> 外文期刊>Scandinavian journal of rheumatology >IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients
【24h】

IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients

机译:意大利IgG4相关疾病:大量患者的临床特征和结局

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: To describe the clinical features, treatment response, and follow-up of a large cohort of Italian patients with immunoglobulin (Ig)G4-related disease (IgG4-RD) referred to a single tertiary care centre.Method: Clinical, laboratory, histological, and imaging features were retrospectively reviewed. IgG4-RD was classified as definite' or possible' according to international consensus guidelines and comprehensive diagnostic criteria for IgG4-RD. Disease activity was assessed by means of the IgG4-RD Responder Index (IgG4-RD RI).Results: Forty-one patients (15 females, 26 males) were included in this study: 26 with definite' IgG4-RD and 15 with possible' IgG4-RD. The median age at diagnosis was 62years. The median follow-up was 36 months (IQR 24-51). A history of atopy was present in 30% of patients. The pancreas, retroperitoneum, and major salivary glands were the most frequently involved organs. Serum IgG4 levels were elevated in 68% of cases. Thirty-six patients were initially treated with glucocorticoids (GCs) to induce remission. IgG4-RD RI decreased from a median of 7.8 at baseline to 2.9 after 1month of therapy. Relapse occurred in 19/41 patients (46%) and required additional immunosuppressive drugs to maintain long-term remission. Multiple flares occurred in a minority of patients. A single case of orbital pseudotumour did not respond to medical therapy and underwent surgical debulking.Conclusions: IgG4-RD is an elusive inflammatory disease to be considered in the differential diagnosis of isolated or multiple tumefactive lesions. Long-term disease control can be achieved with corticosteroids and immunosuppressive drugs in the majority of cases.
机译:目的:描述由一个三级护理中心转诊的一大群意大利免疫球蛋白(Ig)G4相关疾病(IgG4-RD)患者的临床特征,治疗反应和随访情况。方法:临床,实验室,回顾性分析组织学和影像学特征。根据国际共识指南和IgG4-RD的综合诊断标准,IgG4-RD被分类为“肯定”或“可能”。通过IgG4-RD反应指数(IgG4-RD RI)评估疾病活动性。结果:本研究包括41例患者(15例女性,26例男性):26例具有明确的'IgG4-RD,15例可能。 IgG4-RD。诊断时的中位年龄为62岁。中位随访时间为36个月(IQR 24-51)。 30%的患者存在特应性病史。胰腺,腹膜后和主要唾液腺是最常见的器官。 68%的患者血清IgG4水平升高。最初用糖皮质激素(GCs)治疗了36例患者,以诱导缓解。治疗1个月后,IgG4-RD RI从基线的中位数7.8降至2.9。 19/41患者(46%)发生复发,需要额外的免疫抑制药物以维持长期缓解。少数患者发生多发耀斑。一例眼眶假瘤对药物治疗无反应,并接受了手术治疗。结论:IgG4-RD是一种难以捉摸的炎症性疾病,在鉴别单个或多个肿瘤活跃性病变时应予以考虑。在大多数情况下,可以使用皮质类固醇和免疫抑制药物实现长期疾病控制。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号